Cap Dimethyl Fumarate 240 mg Delayed Release, Rivastigmine 9 point 5 mg per 24 hrs Transdermal Patch
Indian Army · Pune, Maharashtra · Pharmaceuticals · open
Key facts
- Tender value: ₹7.4L
- Closing date: 20 Jul 2026
- Status: open
- Ministry: Ministry of Defence
- Department: Department of Military Affairs
Description
Tender for supply of specified pharmaceutical products including Cap Dimethyl Fumarate, Rivastigmine, and others, with a total quantity of 49665 units, issued by the Indian Army under the Ministry of Defence, Department of Military Affairs.
Eligibility & requirements
- Past performance: 60%
- Startup relaxation: Yes
- MSE relaxation: Yes
- Documents required: OEM Authorization Certificate, OEM Annual Turnover Certificate
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: item wise evaluation
- Make in India (MII): Yes
- MSE preference: Yes
Line items (3)
- Cap Dimethyl Fumarate 240 mg Delayed Release — Qty: 49665 unit
- Rivastigmine 9.5 mg per 24 hrs Transdermal Patch — Qty: 49665 unit
- Tab Naproxen plus domperidone 250 plus 10 MG — Qty: 49665 unit
1 tender document(s) available — sign up to download.